Nureca Limited has informed the Exchange regarding Re-appointment of Internal Auditor for the FY 26-27 w.e.f. 01st April,2026 .
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nureca Limited's Board meeting on May 29, 2026 approved multiple items. Financially, the company reported FY26 standalone revenue of Rs 1,472.10 million (up 28% YoY) but a thin net profit of Rs 2.97 million versus a loss of Rs 6.68 million in FY25. Q4 however showed a loss of Rs 66.25 million. Key leadership changes include CFO Mr. Naresh Gupta's resignation effective June 26 (citing better career opportunities), succeeded by Mr. Chander Kant (promoted from Manager Finance) effective June 27. Three related family members were appointed/reappointed as Whole-Time Directors pending shareholder approval: Mr. Aryan Goyal (CEO, reappointed), Mr. Saurabh Goyal (Managing Director, reappointed), and Ms. Smita Goyal (new appointment). The board also approved Rs 100 crore capex for expanding manufacturing at its Derabassi facility and acquiring adjacent land.
The CFO change mid-tenure and new family appointments on the board may raise governance concerns for investors, though the company's return to profitability and expansion plans are positive signals. The promoter family (Goyal siblings and spouse) now holds 45.87% combined shareholding and controls the entire board.